Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021

SELL
$8.57 - $15.79 $124,436 - $229,270
-14,520 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$5.98 - $12.47 $91,828 - $191,489
-15,356 Reduced 51.4%
14,520 $121,000
Q3 2020

Nov 09, 2020

BUY
$4.65 - $8.73 $138,923 - $260,817
29,876 New
29,876 $184,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $553M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.